Chromium acetate stimulates adipogenesis through regulation of gene expression and phosphorylation of adenosine monophosphate-activated protein kinase in bovine intramuscular or subcutaneous adipocytes
3
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective: We hypothesized that Cr source can alter adipogenic-related transcriptional regulations and cell signaling. Therefore, the objective of the study was to evaluate the biological effects of chromium acetate (CrAc) on bovine intramuscular (IM) and subcutaneous (SC) adipose cells. Methods: Bovine preadipocytes isolated from two different adipose tissue depots; IM and SC were used to evaluate the effect of CrAc treatment during differentiation on adipogenic gene expression. Adipocytes were incubated with various doses of CrAc: 0 (differentiation media only, control), 0.1, 1, and 10 μM. Cells were harvested and then analyzed by real-time quantitative polymerase chain reaction in order to measure the quantity of adenosine monophosphate- activated protein kinase-α (AMPK-α), CCAAT enhancer binding protein-β (C/ EBPβ), G protein-coupled receptor 41 (GPR41), GPR43, peroxisome proliferator-activated receptor-γ (PPARγ), and stearoyl CoA desaturase (SCD) mRNA relative to ribosomal protein subunit 9 (RPS9). The ratio of phosphorylated-AMPK (pAMPK) to AMPK was determined using a western blot technique in order to determine changing concentration. Results: The high dose (10 μM) of CrAc increased C/EBPβ, in both IM (p = 0.02) and SC (p = 0.02). Expression of PPARγ was upregulated by 10 μM of CrAc in IM but not in SC. Expression of SCD was also increased in both IM and SC with 10 μM of CrAc treatment. Addition of CrAc did not alter gene expression of glucose transporter 4, GPR41, or GPR43 in both IM and SC adipocytes. Addition of CrAc, resulted in a decreased pAMPKα to AMPKα ration (p<0.01) in IM. Conclusion: These data may indicate that Cr source may influence lipid filling in IM adipocytes via inhibitory action of AMPK phosphorylation and upregulating expression of adipogenic genes.
Abstract
Objective: We hypothesized that Cr source can alter adipogenic-related transcriptional regulations and cell signaling. Therefore, the objective of the study was to evaluate the biological effects of chromium acetate (CrAc) on bovine intramuscular (IM) and subcutaneous (SC) adipose cells. Methods: Bovine preadipocytes isolated from two different adipose tissue depots; IM and SC were used to evaluate the effect of CrAc treatment during differentiation on adipogenic gene expression. Adipocytes were incubated with various doses of CrAc: 0 (differentiation media only, control), 0.1, 1, and 10 μM. Cells were harvested and then analyzed by real-time quantitative polymerase chain reaction in order to measure the quantity of adenosine monophosphate- activated protein kinase-α (AMPK-α), CCAAT enhancer binding protein-β (C/ EBPβ), G protein-coupled receptor 41 (GPR41), GPR43, peroxisome proliferator-activated receptor-γ (PPARγ), and stearoyl CoA desaturase (SCD) mRNA relative to ribosomal protein subunit 9 (RPS9). The ratio of phosphorylated-AMPK (pAMPK) to AMPK was determined using a western blot technique in order to determine changing concentration. Results: The high dose (10 μM) of CrAc increased C/EBPβ, in both IM (p = 0.02) and SC (p = 0.02). Expression of PPARγ was upregulated by 10 μM of CrAc in IM but not in SC. Expression of SCD was also increased in both IM and SC with 10 μM of CrAc treatment. Addition of CrAc did not alter gene expression of glucose transporter 4, GPR41, or GPR43 in both IM and SC adipocytes. Addition of CrAc, resulted in a decreased pAMPKα to AMPKα ration (p<0.01) in IM. Conclusion: These data may indicate that Cr source may influence lipid filling in IM adipocytes via inhibitory action of AMPK phosphorylation and upregulating expression of adipogenic genes.
참고문헌 (40)
- Barnhart J, "Occurrences, uses, and properties of chromium", Regul Toxicol Pharmacol, 26, pp.S3~S7 (1997)[DOI]
- Pechova A, "Chromium as an essential nutrient: a review", Vet Med(Praha), 52, pp.1~ (2007)
- Dowling HJ, "Absorption of inorganic, trivalent chromium from the vascularly perfused rat small intestine", J Nutr, 119, pp.1138~1145 (1989)[DOI]
- Qiao W, "Chromium improves glucose uptake and metabolism through upregulating the mRNA levels of IR, GLUT4, GS, and UCP3 in skeletal muscle cells", Biol Trace Elem Res, 131, pp.133~142 (2009)[DOI]
- Lien TF, "Effect of supplemental levels of chromium picolinate on the growth performance, serum traits, carcass characteristics and lipid metabolism of growing-finishing pigs", Anim Sci, 72, pp.289~296 (2001)[DOI]
- US Food and Drug Administration, "CFR-code of federal regulations title 21 Part 556 tolerances for residues of new animal drugs in food", US Food and Drug Administration, ~ (2017)
- Spears JW, "Chromium supplementation in cattle diets", Florida Rumint Nutrion Symphosium, pp.143~155 (2010)
- Mertz W, "Chromium in human nutrition : a review", J Nutr, 123, pp.626~633 (1993)[DOI]
- Anderson RA, "Supplemental-chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low-chromium diets", Am J Clin Nutr, 54, pp.909~916 (1991)[DOI]
- Mertz W, "Chromium occurrence and function in biological systems", Physiol Rev, 49, pp.163~239 (1969)[DOI]
- Vincent JB, "The biochemistry of chromium", J Nutr, 130, pp.715~718 (2000)[DOI]
- Hoffman NJ, "Chromium enhances insulin responsiveness via AMPK", J Nutr Biochem, 25, pp.565~572 (2014)[DOI]
- Tong JF, "Maternal obesity downregulates myogenesis and β-catenin signaling in fetal skeletal muscle", Am J Physiol Endocrinol Metab, 296, pp.E917~E924 (2009)[DOI]
- Mooney K, "Effects of dietary chromium picolinate supplementation on growth, carcass characteristics, and accretion rates of carcass tissues in growing-finishing swine", J Anim Sci, 73, pp.3351~3357 (1995)[DOI]
- Tokach RJ, "Chromium propionate enhances adipogenic differentiation of bovine intramuscular adipocytes", Front Vet Sci, 2, pp.26~ (2015)[DOI]
- McNamara J, "Adipose tissue metabolism and production responses to calcium propionate and chromium propionate", J Dairy Sci, 88, pp.2498~2507 (2005)[DOI]
- Bionaz M, "Identification of reference genes for quantitative real-time PCR in the bovine mammary gland during the lactation cycle", Physiol Genomics, 29, pp.312~319 (2007)[DOI]
- Janovick-Guretzky N, "Housekeeping gene expression in bovine liver is affected by physiological state, feed intake, and dietary treatment", J Dairy Sci, 90, pp.2246~2252 (2007)[DOI]
- Spears JW, "Chromium propionate enhances insulin sensitivity in growing cattle", J Dairy Sci, 95, pp.2037~2045 (2012)[DOI]
- Burton JL, "Supplemental chromium : its benefits to the bovine immune system", Anim Feed Sci Technol, 53, pp.117~133 (1995)[DOI]
- Bernhard BC, "Chromium supplementation alters the performance and health of feedlot cattle during the receiving period and enhances their metabolic response to a lipopolysaccharide challenge", J Anim Sci, 90, pp.3879~3888 (2012)[DOI]
- Anderson RA, "Beneficial effects of chromium on glucose and lipid variables in control and somatotropin-treated pigs are associated with increased tissue chromium and altered tissue copper, iron, and zinc", J Anim Sci, 75, pp.657~661 (1997)[DOI]
- Kanai F, "Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3 kinase", Biochem Biophys Res Commun, 195, pp.762~768 (1993)[DOI]
- Chen G, "Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism", Mol Endocrinol, 20, pp.857~870 (2006)[DOI]
- Crouse JD, "Bovine muscle glycogen as affected by fasting and refeeding", J Anim Sci, 59, pp.384~387 (1984)[DOI]
- Moonsie-Shageer S, "Effect of level of supplemental chromium on performance, serum constituents, and immune status of stressed feeder calves", J Anim Sci, 71, pp.232~238 (1993)[DOI]
- Villarroya F, "Retinoids and adipose tissues : metabolism, cell differentiation and gene expression", Int J Obes, 23, pp.1~6 (1999)[DOI]
- Symonds ME, "Adipose tissue biology" (2012), Springer
- Janani C, "PPAR gamma gene–a review", Diabetes Metab Syndr Clin Res Rev, 9, pp.46~50 (2015)[DOI]
- van Raalte DH, "Peroxisome proliferator-activated receptor(PPAR)-α : a pharmacological target with a promising future", Pharm Res, 21, pp.1531~1538 (2004)[DOI]
- Smith S, "Starvation depresses acylglycerol biosynthesis in bovine subcutaneous but not intramuscular adipose tissue homogenates", Comp Biochem Physiol B Biochem Mol Biol, 120, pp.165~174 (1998)[DOI]
- Poulos SP, "Cell line models for differentiation : preadipocytes and adipocytes", Exp Biol Med, 235, pp.1185~1193 (2010)[DOI]
- Stephen B. Smith, "Regulation of Fat and Fatty Acid Composition in Beef Cattle", Animal Bioscience, 22(9), pp.1225~1233 (2009), 아세아·태평양축산학회
- Park H, "Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise", J Biol Chem, 277, pp.32571~32577 (2002)[DOI]
- Kelly M, "AMPK activity is diminished in tissues of IL-6 knockout mice : the effect of exercise", Biochem Biophys Res Commun, 320, pp.449~454 (2004)[DOI]
- Orci L, "Rapid transformation of white adipocytes into fat-oxidizing machines", Proc Nat Acad Sci USA, 101, pp.2058~2063 (2004)[DOI]
- Sakoda H, "Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes", Am J Physiol Endocrinol Metab, 282, pp.E1239~E1244 (2002)[DOI]
- Salt IP, "5-aminoimidazole-4-carboxamide ribonucleoside(AICAR)inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes", Diabetes, 49, pp.1649~1656 (2000)[DOI]
- Dagon Y, "AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2α in adipocytes", Biochem Biophys Res Commun, 340, pp.43~47 (2006)[DOI]
- Hawley SA, "Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase", J Biol Chem, 271, pp.27879~27887 (1996)[DOI]
